Gossamer Bio, Inc. (GOSS)
0.353
-0.06
(-15.02%)
USD |
NASDAQ |
Feb 25, 10:55
Gossamer Bio Research and Development Expense (Quarterly) : 45.54M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 115.88M |
| XOMA Royalty Corp. | 0.069M |
| Rezolute, Inc. | 14.35M |
| Axsome Therapeutics, Inc. | 48.68M |
| Crinetics Pharmaceuticals, Inc. | 89.45M |